IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Aug. 4, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX). Class Period: May 23,…

Leave a Reply

Your email address will not be published. Required fields are marked *